Fidelity Investments’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.17M | Buy |
470,717
+284,694
| +153% | +$3.73M | ﹤0.01% | 2089 |
|
|
2025
Q1 | $4.09M | Sell |
186,023
-62,013
| -25% | -$1.36M | ﹤0.01% | 2211 |
|
|
2024
Q4 | $6.62M | Sell |
248,036
-405,172
| -62% | -$10.8M | ﹤0.01% | 2064 |
|
|
2024
Q3 | $17.4M | Sell |
653,208
-4,127,355
| -86% | -$110M | ﹤0.01% | 1757 |
|
|
2024
Q2 | $86.1M | Sell |
4,780,563
-1,585,161
| -25% | -$28.5M | 0.01% | 1104 |
|
|
2024
Q1 | $116M | Sell |
6,365,724
-126,789
| -2% | -$2.31M | 0.01% | 995 |
|
|
2023
Q4 | $71M | Buy |
6,492,513
+89,666
| +1% | +$981K | 0.01% | 1152 |
|
|
2023
Q3 | $36.7M | Sell |
6,402,847
-954,642
| -13% | -$5.47M | ﹤0.01% | 1360 |
|
|
2023
Q2 | $57M | Sell |
7,357,489
-583,053
| -7% | -$4.52M | ﹤0.01% | 1230 |
|
|
2023
Q1 | $53M | Sell |
7,940,542
-648,687
| -8% | -$4.33M | ﹤0.01% | 1242 |
|
|
2022
Q4 | $76.8M | Buy |
8,589,229
+612,416
| +8% | +$5.47M | 0.01% | 1070 |
|
|
2022
Q3 | $78.5M | Buy |
7,976,813
+5,161,529
| +183% | +$50.8M | 0.01% | 1050 |
|
|
2022
Q2 | $22.4M | Buy |
2,815,284
+293,834
| +12% | +$2.34M | ﹤0.01% | 1606 |
|
|
2022
Q1 | $24.5M | Buy |
2,521,450
+21,351
| +0.9% | +$207K | ﹤0.01% | 1703 |
|
|
2021
Q4 | $38.2M | Sell |
2,500,099
-654,573
| -21% | -$10M | ﹤0.01% | 1535 |
|
|
2021
Q3 | $52.4M | Buy |
3,154,672
+739,454
| +31% | +$12.3M | ﹤0.01% | 1388 |
|
|
2021
Q2 | $51.5M | Buy |
2,415,218
+884,800
| +58% | +$18.9M | ﹤0.01% | 1411 |
|
|
2021
Q1 | $49.7M | Buy |
+1,530,418
| New | +$49.7M | ﹤0.01% | 1402 |
|